Amazon Biotech Announces Issuance Of Patent For A Unique Formulation And Method Of Treating HIV Infection

NEW YORK, NY -- (MARKET WIRE) -- February 16, 2007 -- Amazon Biotech, Inc. (OTCBB: AMZB) (FRANKFURT: B2D) announced that it has been issued a patent from the United States Patent and Trademark Office, patent # 7,160,561 for “a herbal composition and method of treating HIV infection.”

MORE ON THIS TOPIC